BioStem Technologies, Inc. (BSEM)

BioStem Technologies Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net Income	-0.54	-8.48	-7.07	-1.45	-2.39	-6.38
Depreciation & Amortization	0.22	0.23	0.24	0.28	0.24	0.33
Share-Based Compensation	2.86	6.66	4.9	0.4	0	0
Other Operating Activities	-4.82	-1.91	0.29	0.65	1.56	5.2
Operating Cash Flow	-2.28	-3.5	-1.64	-0.11	-0.58	-0.85
Capital Expenditures	-0.06	-0.21	-0.47	-0.04	-0	-0.13
Acquisitions	0	0	0	0.04	0	0.18
Other Investing Activities	0	-	-	-	-	-
Investing Cash Flow	-0.06	-0.21	-0.47	-0.01	-0	0.05
Common Stock Issued	2.42	2.38	0.05	0.13	0	0
Other Financing Activities	0.41	0.8	0.52	0.23	0.54	-0.24
Financing Cash Flow	2.83	3.18	0.57	0.36	0.54	-0.24
Net Cash Flow	0.49	-0.53	0.43	0.24	-0.04	-1.04
Free Cash Flow	-2.33	-3.71	-2.11	-0.15	-0.59	-0.98
Free Cash Flow Margin	-4.02%	-22.23%	-30.64%	-3.51%	-23.21%	-37.23%
Free Cash Flow Per Share	-0.10	-0.27	-0.18	-0.01	-0.06	-0.11

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.